149 related articles for article (PubMed ID: 26311306)
21. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
22. Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer.
Yao Q; Zhang AM; Ma H; Lin S; Wang XX; Sun JG; Chen ZT
Mol Cell Probes; 2012 Oct; 26(5):182-7. PubMed ID: 22796123
[TBL] [Abstract][Full Text] [Related]
23. Combination of serum miRNAs with Cyfra21-1 for the diagnosis of non-small cell lung cancer.
Zhou C; Chen Z; Dong J; Li J; Shi X; Sun N; Luo M; Zhou F; Tan F; He J
Cancer Lett; 2015 Oct; 367(2):138-46. PubMed ID: 26213369
[TBL] [Abstract][Full Text] [Related]
24. Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer.
Roa WH; Kim JO; Razzak R; Du H; Guo L; Singh R; Gazala S; Ghosh S; Wong E; Joy AA; Xing JZ; Bedard EL
Clin Invest Med; 2012 Oct; 35(5):E271. PubMed ID: 23043708
[TBL] [Abstract][Full Text] [Related]
25. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
26. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
27. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
[TBL] [Abstract][Full Text] [Related]
29. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
Zeng XL; Zhang SY; Zheng JF; Yuan H; Wang Y
Chin Med J (Engl); 2013 Dec; 126(23):4510-6. PubMed ID: 24286416
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
31. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.
Li ZH; Zhang H; Yang ZG; Wen GQ; Cui YB; Shao GG
J Int Med Res; 2013 Oct; 41(5):1437-44. PubMed ID: 24065453
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
[TBL] [Abstract][Full Text] [Related]
35. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
[TBL] [Abstract][Full Text] [Related]
36. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.
Lu S; Kong H; Hou Y; Ge D; Huang W; Ou J; Yang D; Zhang L; Wu G; Song Y; Zhang X; Zhai C; Wang Q; Zhu H; Wu Y; Bai C
Lung Cancer; 2018 Sep; 123():44-51. PubMed ID: 30089594
[TBL] [Abstract][Full Text] [Related]
37. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
[TBL] [Abstract][Full Text] [Related]
38. Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection.
Sromek M; Glogowski M; Chechlinska M; Kulinczak M; Szafron L; Zakrzewska K; Owczarek J; Wisniewski P; Wlodarczyk R; Talarek L; Turski M; Siwicki JK
Cell Oncol (Dordr); 2017 Oct; 40(5):529-536. PubMed ID: 28634901
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
40. Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer.
Campayo M; Navarro A; Viñolas N; Diaz T; Tejero R; Gimferrer JM; Molins L; Cabanas ML; Ramirez J; Monzo M; Marrades R
Eur Respir J; 2013 May; 41(5):1172-8. PubMed ID: 22835608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]